Pharmacokinetics and Pharmacodynamics
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
“Pharmacokinetics and Pharmacodynamics” is a Section of the peer-reviewed open access journal Pharmaceutics, which is devoted to highlighting the importance of pharmacokinetics and pharmacodynamics in drug development for better understanding of drug action. The Section welcomes original research articles as well as review papers that address a variety of related topics to novel and significant scientific findings by in vitro, in vivo, and clinical studies. The manuscript mainly focused on descriptive pharmacokinetics lacking novelty and scientific significance will not be considered for review.
Covered topics include:
- Mechanisms and factors affecting drug absorption, distribution, metabolism, and excretion;
- Kinetics of drug disposition and therapeutic effects;
- Pharmacokinetics, pharmacodynamics, and pharmacometrics;
- Toxicokinetics and toxicodynamics;
- Mathematical model for the assessment of drug ADME;
- Model-based drug development;
- Translational mathematical modeling in drug development;
- Quantitative systems pharmacology.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy, 2nd Edition (Deadline: 10 October 2024)
- Advances in Pharmacokinetics and Drug Interactions (Deadline: 20 October 2024)
- Mechanism-Based Pharmacokinetic and Pharmacodynamic Modeling (Deadline: 31 October 2024)
- Development of Physiologically Based Pharmacokinetic (PBPK) Modeling (Deadline: 31 October 2024)
- Precision Dosing in Clinical Therapeutics: The Application of Pharmacokinetics and Pharmacometrics (Deadline: 10 November 2024)
- New Insights into Physiologically Based Pharmacokinetic Modeling (Deadline: 10 November 2024)
- Emerging Trends in Bioequivalence Research (Deadline: 20 November 2024)
- Mechanisms of Drug Interactions: Pharmacodynamics and Pharmacokinetics (Deadline: 30 November 2024)
- Pharmacokinetics and Drug–Drug Interactions of Novel Psychotropic Drugs (Deadline: 31 December 2024)
- Physiologically-Based Pharmacokinetics (PBPK) and Biopharmaceutics (PBBM) Modeling for Formulation Development (Deadline: 31 December 2024)
- Pharmacokinetic and Pharmacodynamic Considerations for Drugs Used in the Treatment of Cardiovascular Diseases (Deadline: 20 January 2025)
- Pharmacokinetics of Drugs in Pregnancy and Lactation (Deadline: 31 January 2025)
- Effects of Obesity on Pharmacokinetics (Deadline: 31 January 2025)
- Formulation Strategies to Optimize Drug Pharmacokinetics and Improve Therapeutic Outcomes (Deadline: 31 January 2025)
- Role of Pharmacokinetics in Drug Development and Evaluation (Deadline: 20 February 2025)
- Novel Anti-cancer Compounds: Drug Metabolism and Absorption (Deadline: 20 February 2025)
- ADME Properties in the Drug Delivery (Deadline: 10 March 2025)
- Advancing Biologic Drug Development Through Physiologically Based Pharmacokinetic Modelling and Simulations (Deadline: 10 March 2025)
- Population Pharmacokinetics and Its Clinical Applications (Deadline: 20 March 2025)
- Pathophysiological Influences on Pharmacokinetics and Pharmacodynamics (Deadline: 31 March 2025)
